| Effectiveness of Electric Stimulation Therapy in Raynaud's Phenomenon (NCT03699436) | Universidad de Granada | 2018-10-01 |
| Investigation of the Rewarming og the Fingers After Cooling and the Autonomic Nervous System in Raynaud's Phenomenon (NCT03094910) | Herlev Hospital | 2017-01-01 |
| Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud (NCT03027674) | Pontificia Universidad Catolica de Chile | 2016-08-01 |
| A Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP) (NCT02506062) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2015-07-01 |
| Treatment of Digital Ulcers in Korean Patients With Systemic Sclerosis: a Prospective Cohort Study (NCT02642146) | Seoul National University Hospital | 2015-01-01 |
| Metabolomic Analysis of Systemic Sclerosis (NCT02298777) | University Hospital, Strasbourg, France | 2014-12-01 |
| Exparel as a Nerve Block for Severe Hand Pain (NCT02374320) | Jose Soberon, MD | 2014-11-01 |
| PORH and Response to Cold in Raynaud's Phenomenon. (NCT02183779) | University Hospital, Grenoble | 2014-06-01 |
| Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator (NCT01926847) | Bayer | 2013-10-01 |
| Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis. (NCT01743612) | University Hospital, Grenoble | 2012-01-01 |
| Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms (NCT00934427) | MediQuest Therapeutics | 2009-06-01 |
| Randomised Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma (NCT00626665) | Sanjay Gandhi Postgraduate Institute of Medical Sciences | 2007-12-01 |
| Efficacy and Tolerability of Ginkgo Biloba Extract in Patients With Raynaud´s Phenomenon (NCT00251238) | VSM Geneesmiddelen b.v. | 2005-11-01 |
| Lab Study of MQX-503 in Treatment of Raynaud's (NCT00253331) | MediQuest Therapeutics | 2004-11-01 |
| Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis (NCT00004786) | National Center for Research Resources (NCRR) | 1995-12-01 |